REGISTERED AND RENEWED
on 08 Apr 2024
Last Applicant/ Owned by
9715 Key West Avenue
Rockville
MD
20850
Serial Number
85732114 filed on 18th Sep 2012
Registration Number
4441262 registered on 26th Nov 2013
Correspondent Address
Mark D. Simpson
Mark D. Simpson Saul Ewing LLP
Centre Square West, 38th Floor
PHILADELPHIA, PA 19102-2128
UNITED STATES
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
OXTELLAR XR
Pharmaceutical preparations or substances for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations or substances for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
First Use Date in General
28th Feb 2013
First Use Date in Commerce
28th Feb 2013
Mark Details
Serial Number
No 85732114
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 356969.00034
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 08th Apr 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| 08th Apr 2024 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| 08th Apr 2024 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 08th Apr 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 27th Nov 2023 | TEAS SECTION 8 & 9 RECEIVED |
| 26th Nov 2022 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 18th Jan 2020 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 18th Jan 2020 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 18th Jan 2020 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 26th Nov 2019 | TEAS SECTION 8 & 15 RECEIVED |